nodes	percent_of_prediction	percent_of_DWPC	metapath
Meropenem—Application site pain—Dapsone—leprosy	0.0543	0.0543	CcSEcCtD
Meropenem—Hypochromic anaemia—Thalidomide—leprosy	0.0315	0.0315	CcSEcCtD
Meropenem—Peripheral vascular disorder—Thalidomide—leprosy	0.0249	0.0249	CcSEcCtD
Meropenem—White blood cell count decreased—Thalidomide—leprosy	0.0246	0.0246	CcSEcCtD
Meropenem—Blood lactate dehydrogenase increased—Thalidomide—leprosy	0.021	0.021	CcSEcCtD
Meropenem—Platelet count decreased—Thalidomide—leprosy	0.0205	0.0205	CcSEcCtD
Meropenem—Enlargement abdomen—Thalidomide—leprosy	0.0203	0.0203	CcSEcCtD
Meropenem—Oral candidiasis—Thalidomide—leprosy	0.0192	0.0192	CcSEcCtD
Meropenem—Hypomagnesaemia—Thalidomide—leprosy	0.0192	0.0192	CcSEcCtD
Meropenem—Intestinal obstruction—Thalidomide—leprosy	0.0179	0.0179	CcSEcCtD
Meropenem—Cholestasis—Thalidomide—leprosy	0.0161	0.0161	CcSEcCtD
Meropenem—Pleural effusion—Thalidomide—leprosy	0.016	0.016	CcSEcCtD
Meropenem—Skin ulcer—Thalidomide—leprosy	0.0157	0.0157	CcSEcCtD
Meropenem—Apnoea—Thalidomide—leprosy	0.0144	0.0144	CcSEcCtD
Meropenem—Jaundice cholestatic—Thalidomide—leprosy	0.0139	0.0139	CcSEcCtD
Meropenem—Accidental injury—Thalidomide—leprosy	0.0138	0.0138	CcSEcCtD
Meropenem—Neuropathy peripheral—Dapsone—leprosy	0.0131	0.0131	CcSEcCtD
Meropenem—Leukocytosis—Thalidomide—leprosy	0.013	0.013	CcSEcCtD
Meropenem—Creatinine increased—Thalidomide—leprosy	0.0128	0.0128	CcSEcCtD
Meropenem—Pulmonary embolism—Thalidomide—leprosy	0.0122	0.0122	CcSEcCtD
Meropenem—Pharyngitis—Dapsone—leprosy	0.0119	0.0119	CcSEcCtD
Meropenem—Colitis—Thalidomide—leprosy	0.0117	0.0117	CcSEcCtD
Meropenem—Candida infection—Thalidomide—leprosy	0.0117	0.0117	CcSEcCtD
Meropenem—Blood urea increased—Thalidomide—leprosy	0.0115	0.0115	CcSEcCtD
Meropenem—Neuropathy—Thalidomide—leprosy	0.0115	0.0115	CcSEcCtD
Meropenem—Pulmonary oedema—Thalidomide—leprosy	0.0109	0.0109	CcSEcCtD
Meropenem—Sepsis—Thalidomide—leprosy	0.0106	0.0106	CcSEcCtD
Meropenem—Erythema—Dapsone—leprosy	0.0104	0.0104	CcSEcCtD
Meropenem—Thrombophlebitis—Thalidomide—leprosy	0.0102	0.0102	CcSEcCtD
Meropenem—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.0102	0.0102	CcSEcCtD
Meropenem—Injury—Thalidomide—leprosy	0.00965	0.00965	CcSEcCtD
Meropenem—Cough—Dapsone—leprosy	0.00911	0.00911	CcSEcCtD
Meropenem—Hypoglycaemia—Thalidomide—leprosy	0.00909	0.00909	CcSEcCtD
Meropenem—Cardiac failure—Thalidomide—leprosy	0.00909	0.00909	CcSEcCtD
Meropenem—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00887	0.00887	CcSEcCtD
Meropenem—Cardiac arrest—Thalidomide—leprosy	0.00844	0.00844	CcSEcCtD
Meropenem—Tachycardia—Dapsone—leprosy	0.00831	0.00831	CcSEcCtD
Meropenem—Blood creatinine increased—Thalidomide—leprosy	0.00831	0.00831	CcSEcCtD
Meropenem—Hypokalaemia—Thalidomide—leprosy	0.00807	0.00807	CcSEcCtD
Meropenem—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00799	0.00799	CcSEcCtD
Meropenem—Aspartate aminotransferase increased—Thalidomide—leprosy	0.00799	0.00799	CcSEcCtD
Meropenem—Alanine aminotransferase increased—Thalidomide—leprosy	0.00782	0.00782	CcSEcCtD
Meropenem—Abdominal distension—Thalidomide—leprosy	0.00772	0.00772	CcSEcCtD
Meropenem—Insomnia—Dapsone—leprosy	0.0077	0.0077	CcSEcCtD
Meropenem—Eosinophilia—Thalidomide—leprosy	0.00759	0.00759	CcSEcCtD
Meropenem—Neutropenia—Thalidomide—leprosy	0.00717	0.00717	CcSEcCtD
Meropenem—Gastrointestinal pain—Dapsone—leprosy	0.00697	0.00697	CcSEcCtD
Meropenem—Pneumonia—Thalidomide—leprosy	0.00688	0.00688	CcSEcCtD
Meropenem—Infestation NOS—Thalidomide—leprosy	0.00684	0.00684	CcSEcCtD
Meropenem—Infestation—Thalidomide—leprosy	0.00684	0.00684	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00678	0.00678	CcSEcCtD
Meropenem—Acute coronary syndrome—Thalidomide—leprosy	0.00674	0.00674	CcSEcCtD
Meropenem—Abdominal pain—Dapsone—leprosy	0.00673	0.00673	CcSEcCtD
Meropenem—Body temperature increased—Dapsone—leprosy	0.00673	0.00673	CcSEcCtD
Meropenem—Renal failure—Thalidomide—leprosy	0.00672	0.00672	CcSEcCtD
Meropenem—Neuropathy peripheral—Thalidomide—leprosy	0.0067	0.0067	CcSEcCtD
Meropenem—Myocardial infarction—Thalidomide—leprosy	0.0067	0.0067	CcSEcCtD
Meropenem—Sweating—Thalidomide—leprosy	0.00655	0.00655	CcSEcCtD
Meropenem—Epistaxis—Thalidomide—leprosy	0.00645	0.00645	CcSEcCtD
Meropenem—Agranulocytosis—Thalidomide—leprosy	0.00638	0.00638	CcSEcCtD
Meropenem—Bradycardia—Thalidomide—leprosy	0.00625	0.00625	CcSEcCtD
Meropenem—Hepatitis—Thalidomide—leprosy	0.00614	0.00614	CcSEcCtD
Meropenem—Pharyngitis—Thalidomide—leprosy	0.00609	0.00609	CcSEcCtD
Meropenem—Oedema peripheral—Thalidomide—leprosy	0.00605	0.00605	CcSEcCtD
Meropenem—Erythema multiforme—Thalidomide—leprosy	0.0058	0.0058	CcSEcCtD
Meropenem—Immune system disorder—Thalidomide—leprosy	0.00554	0.00554	CcSEcCtD
Meropenem—Chills—Thalidomide—leprosy	0.00551	0.00551	CcSEcCtD
Meropenem—Vomiting—Dapsone—leprosy	0.00542	0.00542	CcSEcCtD
Meropenem—Headache—Dapsone—leprosy	0.00534	0.00534	CcSEcCtD
Meropenem—Flatulence—Thalidomide—leprosy	0.00526	0.00526	CcSEcCtD
Meropenem—Tension—Thalidomide—leprosy	0.00524	0.00524	CcSEcCtD
Meropenem—Dysgeusia—Thalidomide—leprosy	0.00523	0.00523	CcSEcCtD
Meropenem—Nervousness—Thalidomide—leprosy	0.00519	0.00519	CcSEcCtD
Meropenem—Back pain—Thalidomide—leprosy	0.00517	0.00517	CcSEcCtD
Meropenem—Nausea—Dapsone—leprosy	0.00506	0.00506	CcSEcCtD
Meropenem—Anaemia—Thalidomide—leprosy	0.00494	0.00494	CcSEcCtD
Meropenem—Agitation—Thalidomide—leprosy	0.00491	0.00491	CcSEcCtD
Meropenem—Angioedema—Thalidomide—leprosy	0.00488	0.00488	CcSEcCtD
Meropenem—Malaise—Thalidomide—leprosy	0.00482	0.00482	CcSEcCtD
Meropenem—Syncope—Thalidomide—leprosy	0.00479	0.00479	CcSEcCtD
Meropenem—Leukopenia—Thalidomide—leprosy	0.00478	0.00478	CcSEcCtD
Meropenem—Loss of consciousness—Thalidomide—leprosy	0.0047	0.0047	CcSEcCtD
Meropenem—Cough—Thalidomide—leprosy	0.00466	0.00466	CcSEcCtD
Meropenem—Hypertension—Thalidomide—leprosy	0.00461	0.00461	CcSEcCtD
Meropenem—Chest pain—Thalidomide—leprosy	0.00455	0.00455	CcSEcCtD
Meropenem—Anxiety—Thalidomide—leprosy	0.00453	0.00453	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00452	0.00452	CcSEcCtD
Meropenem—Confusional state—Thalidomide—leprosy	0.0044	0.0044	CcSEcCtD
Meropenem—Oedema—Thalidomide—leprosy	0.00436	0.00436	CcSEcCtD
Meropenem—Infection—Thalidomide—leprosy	0.00433	0.00433	CcSEcCtD
Meropenem—Shock—Thalidomide—leprosy	0.00429	0.00429	CcSEcCtD
Meropenem—Nervous system disorder—Thalidomide—leprosy	0.00428	0.00428	CcSEcCtD
Meropenem—Thrombocytopenia—Thalidomide—leprosy	0.00427	0.00427	CcSEcCtD
Meropenem—Tachycardia—Thalidomide—leprosy	0.00426	0.00426	CcSEcCtD
Meropenem—Skin disorder—Thalidomide—leprosy	0.00424	0.00424	CcSEcCtD
Meropenem—Hyperhidrosis—Thalidomide—leprosy	0.00422	0.00422	CcSEcCtD
Meropenem—Anorexia—Thalidomide—leprosy	0.00416	0.00416	CcSEcCtD
Meropenem—Hypotension—Thalidomide—leprosy	0.00407	0.00407	CcSEcCtD
Meropenem—Insomnia—Thalidomide—leprosy	0.00394	0.00394	CcSEcCtD
Meropenem—Paraesthesia—Thalidomide—leprosy	0.00392	0.00392	CcSEcCtD
Meropenem—Dyspnoea—Thalidomide—leprosy	0.00389	0.00389	CcSEcCtD
Meropenem—Somnolence—Thalidomide—leprosy	0.00388	0.00388	CcSEcCtD
Meropenem—Dyspepsia—Thalidomide—leprosy	0.00384	0.00384	CcSEcCtD
Meropenem—Decreased appetite—Thalidomide—leprosy	0.00379	0.00379	CcSEcCtD
Meropenem—Gastrointestinal disorder—Thalidomide—leprosy	0.00376	0.00376	CcSEcCtD
Meropenem—Pain—Thalidomide—leprosy	0.00373	0.00373	CcSEcCtD
Meropenem—Constipation—Thalidomide—leprosy	0.00373	0.00373	CcSEcCtD
Meropenem—Feeling abnormal—Thalidomide—leprosy	0.00359	0.00359	CcSEcCtD
Meropenem—Gastrointestinal pain—Thalidomide—leprosy	0.00357	0.00357	CcSEcCtD
Meropenem—Urticaria—Thalidomide—leprosy	0.00346	0.00346	CcSEcCtD
Meropenem—Abdominal pain—Thalidomide—leprosy	0.00345	0.00345	CcSEcCtD
Meropenem—Body temperature increased—Thalidomide—leprosy	0.00345	0.00345	CcSEcCtD
Meropenem—Hypersensitivity—Thalidomide—leprosy	0.00321	0.00321	CcSEcCtD
Meropenem—Asthenia—Thalidomide—leprosy	0.00313	0.00313	CcSEcCtD
Meropenem—Pruritus—Thalidomide—leprosy	0.00308	0.00308	CcSEcCtD
Meropenem—Diarrhoea—Thalidomide—leprosy	0.00298	0.00298	CcSEcCtD
Meropenem—Dizziness—Thalidomide—leprosy	0.00288	0.00288	CcSEcCtD
Meropenem—Vomiting—Thalidomide—leprosy	0.00277	0.00277	CcSEcCtD
Meropenem—Rash—Thalidomide—leprosy	0.00275	0.00275	CcSEcCtD
Meropenem—Dermatitis—Thalidomide—leprosy	0.00275	0.00275	CcSEcCtD
Meropenem—Headache—Thalidomide—leprosy	0.00273	0.00273	CcSEcCtD
Meropenem—Nausea—Thalidomide—leprosy	0.00259	0.00259	CcSEcCtD
